Chemical Structure : Povorcitinib
CAS No.: 1637677-22-5
货号: PC-73438Not For Human Use, Lab Use Only.
Povorcitinib (INCB054707) is a potent, selective and oral JAK1 inhibitor with IC50 of 8.9 nM, 52-fold selective over JAK2 (IC50=463 nM).
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
5 mg | ¥2380 | In stock | |
10 mg | ¥3780 | In stock | |
25 mg | ¥5980 | In stock | |
50 mg | Get quote | ||
100 mg | Get quote |
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
Povorcitinib (INCB054707) is a potent, selective and oral JAK1 inhibitor with IC50 of 8.9 nM, 52-fold selective over JAK2 (IC50=463 nM).
Povorcitinib (INCB054707) reduces IFN signaling and ameliorates cutaneous lesions in systemic lupus erythematosus (SLE).
Povorcitinib (INCB054707) dose-dependently reduced the incidence and severity of cutaneous lesion, abrogated lymphoid tissue and spleen enlargement in a preclinical model of cutaneous lupus erythematosus.
分子量 | 507.469 | |
分子式 | C23H22F5N7O | |
外观性状 | Solid | |
储存条件 |
|
|
Solubility |
10 mM in DMSO |
|
Chemical Name/SMILES |
(S)-4-(3-(Cyanomethyl)-3-(3',5'-dimethyl-1H,1'H-[4,4'-bipyrazol]-1-yl)azetidin-1-yl)-2,5-difluoro-N-(1,1,1-trifluoropropan-2-yl)benzamide |
1. Alavi A, et al. Br J Dermatol. 2022 May;186(5):803-813.
2. Fay B, He X, Margulis A et al. Ann Rheum Dis 2019; 78 (Suppl. 2):221–2.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright